Publications
- Phosphatidylserine-dependent anti-prothrombin antibodies (aPS/PT) in infliximab-treated patients with inflammatory bowel diseases2013 | First Faculty of Medicine
- Serum infliximab trough levels and induction of antibodies to infliximab in patients with inflammatory bowel diseases2011 | First Faculty of Medicine
- Anti-infliximab antibodies in routine clinical practice - is it worth to assess them?Publication without faculty affiliation
- Determination of serum infliximab levels and levels of antibodies against infliximab - when, why and how?Publication without faculty affiliation
- Serum infliximab levels, antibodies to infliximab and albumin concentrations during infliximab treatment in patients with inflammatory bowel diseasesPublication without faculty affiliation
- Formation of antiphospholipid antibodies and antibodies to infliximab in anti-TNF-alpha antibody treated patients with inflammatory bowel diseasesPublication without faculty affiliation
- A switch from originator-adalimumab to the biosimilar SB5 in patients with Crohn's disease: an analysis of two propensity score-matched cohorts2022 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Telemedicine and inflammatory bowel disease - results of the IBD Assistant pilot project2020 | Faculty of Physical Education and Sport, First Faculty of Medicine
- Iron substitution in sideropenia or sideropenic anemia in patients with IBD with heme iron containing preparation2020 | First Faculty of Medicine, Central Library of Charles University
- Biosimilar adalimumab in clinical practice2020 | First Faculty of Medicine
Loading network view...